Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-36,269
Closed -$89.6K 2363
2025
Q1
$89.6K Sell
36,269
-19
-0.1% -$45 ﹤0.01% 2498
2024
Q4
$114K Sell
36,288
-2,740
-7% -$13.3K ﹤0.01% 2491
2024
Q3
$192K Sell
39,028
-241
-0.6% -$1.24K ﹤0.01% 2248
2024
Q2
$173K Buy
+39,269
New +$184K ﹤0.01% 2281

Other funds holding SLRN

Corebridge Financial's SLRN Position: Q2 2025 in Review

Corebridge Financial sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 36,269 shares — an estimated $89.6K sold.

Corebridge Financial first reported a position in SLRN in Q2 2024 and held it in 4 quarters. The position peaked at $192K in Q3 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Corebridge Financial reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 36,269 ACELYRIN shares in Q2 2025, an estimated $89.6K.
  • Corebridge Financial first reported a position in ACELYRIN in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's ACELYRIN position peaked at $192K in Q3 2024.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.